Sign up to save your podcasts
Or
Share Oncology Unscripted With John Marshall
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Oncology Unscripted With John Marshall
Oncology Unscripted With John Marshall episodes
- Oncology Unscripted With John Marshall: Episode 36: What Do Politics, Mergers, and Blood Tests Mean for Cancer Care?
Main Topic
In this episode of Oncology Unscripted, Dr John Marshall examines a White House push for final sign-off on NIH grants and what politicizing science could mean for research and health equity in cancer care. He also looks at merger talks between AstraZeneca and Bristol Myers Squibb and weighs both sides of the discussion surrounding blood tests for cancer screening.MedBuzz
In this MedBuzz, Dr John Marshall reflects on a week of Zoom interviews for a new cancer center director, a head pastor, and fellowship candidates, and on how hard it has become to get butts in chairs at in-person medical meetings and where we go from here.Interview
In this Candid Conversation, John Marshall, MD, Lucile Adams-Campbell, PhD, and Monica Baskin, PhD, discuss breakthroughs in cancer center leadership, including Dr Baskin becoming the first Black woman to lead a cancer center designated by the National Cancer Institute. They also talk about mentorship, the women who paved the way, and why politics has no place in science.
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
34 min - Oncology Unscripted With John Marshall: Episode 35: Can AI Help Personalize Cancer Treatment Decisions?
Main Topic
In this episode of Oncology Unscripted, Dr. John Marshall explores how new approaches are shaping cancer treatment decisions, from using AI to help personalize treatment for individual patients to the unexpected results of a randomized trial of adagrasib in colorectal cancer. He also examines how precision medicine may help guide treatment for patients with cancers of unknown primary.MedBuzz
In this MedBuzz, Dr John Marshall examines the rising cost of cancer treatments and the difficult questions surrounding the value of innovation including the nearly $40,000 monthly price of daraxonrasib, and the broader challenge of balancing medical advances with access to care.Interview
In this Candid Conversation, John Marshall, MD, and Derek Raghavan, MD, PhD, discuss the business of cancer care, including treatment costs, value, financial toxicity, incentives in oncology, and the importance of honest conversations about the benefits and burdens of treatment.
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
36 min - Oncology Unscripted With John Marshall: Episode 34: mRNA Vaccine Advances Melanoma Care Amid Growing Vaccine Hesitancy
Main Topic
In this episode of Oncology Unscripted, Dr John Marshall reflects on growing vaccine hesitancy and contrasts that with new reports that a personalized melanoma messenger RNA vaccine improved outcomes in a phase 3 study.MedBuzz
In this MedBuzz, Dr John Marshall reflects on recent changes in prescription drug pricing and the rapid rise of GLP-1 receptor agonists, their long-term impacts, and how he handles answers to questions from patients about impacts on cancer outcomes.Interview
In this episode of Oncology Unscripted, John Marshall, MD, speaks with evolutionary biologist Daniel E. Lieberman, PhD, author of Fed Up, about the connections between physical activity, nutrition, the microbiome, and cancer prevention.
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
35 min - Oncology Unscripted With John Marshall: Episode 33: When Dogs Detect Cancer
Main Topic
In this episode of Oncology Unscripted, Dr Marshall examines the evolving role of blood-based cancer screening and highlights new research showing how dogs may help detect early cancers from breath samples.Alternative Data Centers, Medicine, and AI Guilt?
In MedBuzz, Dr Marshall discusses the emergence of betting on clinical trial outcomes, the rise of AI in medicine, the environmental impact of data centers, and whether growing reliance on artificial intelligence should leave clinicians with a sense of AI guilt.
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
14 min - Oncology Unscripted With John Marshall: Episode 32: Post-ASCO Roundup: RAS, Research, and the Road Ahead
Main Topic:
In this episode of Oncology Unscripted, Dr John Marshall discusses major post-ASCO developments in GI oncology, including new RAS inhibitor data in pancreatic cancer and the path forward.MedBuzz:
In this episode of Oncology Unscripted, Dr John Marshall reflects on a trip to South Africa and what it revealed about survival, inequity, and the luxury of modern cancer care. Through experiences in Johannesburg and on safari, he connects cancer care access to broader questions of privilege, community, and responsibility.Interview:
In this episode of Oncology Unscripted, Dr John Marshall speaks with global oncology experts about cancer care access and the barriers that limit availability of new treatments and testing worldwide. The discussion examines drug pricing, reimbursement, value, and the need for more equitable access to cancer care.
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
41 min - Oncology Unscripted With John Marshall: Episode 31: ASCO 2026 Preview: Precision Medicine, MRD, and the Next Wave of Care
MedBuzz:
In this episode of Oncology Unscripted, John Marshall, MD, discusses a troubling week in health care news, including upheaval at the FDA, concerns about reduced federal support for medical education, and growing evidence that AI-generated fabricated references are appearing in published scientific literature.Main Topic:
In this episode of Oncology Unscripted, Dr John Marshall previews the practice-changing data expected at ASCO 2026, highlighting advances in precision medicine. Tune in to hear which presentations could shape the next wave of cancer care.
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
13 min - Oncology Unscripted With John Marshall: Episode 30: Navigating the Expanding Role of Precision Medicine
MedBuzz:
In this episode of Oncology Unscripted MedBuzz, Dr Marshall discusses evolving rectal cancer data and the growing role of genomic testing. He also reflects on US science policy and concerns about instability, and the need to modernize clinical trials while protecting independent oversight and patient data.Main Topic:
In this episode of Oncology Unscripted, Dr Marshall discusses the growing role of precision medicine in oncology and how it is shifting from an optional tool to a standard part of cancer care, including the increasing importance of MRD and ctDNA, and promise of blood-based cancer screening.Interview:
In this episode of Candid Conversations , Dr. John Marshall speaks with Dr. Marija Balic of UPMC and the University of Pittsburgh about MRD ctDNA testing in early breast cancer.
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
32 min - Oncology Unscripted With John Marshall: Episode 29: AI in Cancer Care: Promise, Pressure, and the Physician’s Role
MedBuzz:
In this MedBuzz, Dr John Marshall discusses Steve Ubl’s departure from PhRMA and what it may signal for drug pricing, pharmaceutical policy, payer dynamics, and patient access.Main Topic:
In this episode of Oncology Unscripted, Dr John Marshall explores the growing role of AI in cancer care, from analyzing patient data and predicting treatment responses to supporting clinical trials, guidelines, manuscripts, and patient communication. He also reflects on the risks of AI, including privacy, bias, accountability, energy demands, and the potential loss of human connection in medicine.Interview:
In this expert panel discussion of Oncology Unscripted, Dr John Marshall explores how artificial intelligence is being used in health care today and where it may be headed next. Guests Neel Trivedi, MD; Ross Filice, MD; and Torbjørn Furuseth, MD, discuss AI scribes, radiology, digital pathology, clinical decision-making, patient privacy, and the ongoing role of human judgment in medicine.
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
39 min - Oncology Unscripted With John Marshall: Episode 28: Are We Watching a Global Evolution in Cancer Care Leadership?
MedBuzz:
After a trip to the Galapagos, Dr John Marshall reflects on evolution in nature, cancer, and medicine. From Darwin’s observations to the rise of AI and precision oncology, he explores how rapidly cancer adapts, how technology is reshaping care, and why the future of medicine must still preserve the human touch.Main Topic:
In this episode of Oncology Unscripted, Dr John Marshall reflects on a practice-changing cholangiocarcinoma study from China and what it reveals about the rapid evolution of cancer research worldwide. As novel therapies transform care and China expands its investment in science while the US devests, he asks whether we can keep pace and the impacts of the global evolution of in oncology.Interview:
Watch now as Dr John Marshall sits down with Dr Louis Weiner, director of Georgetown University’s Lombardi Cancer Center, for a candid conversation about leadership, scientific change, and the future of oncology. Reflecting on innovation, institutional transition, and the pressures reshaping cancer research, they explore what it means to evolve as a leader and honoring the work and the people.
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
31 min - Oncology Unscripted With John Marshall: Episode 27: Groundhog Day, The Ice Palace, and $25 Trillion Cancer CostsMedBuzz:Watch now as Dr Marshall discusses the growing instability at the FDA, including job cuts, leadership turnover, and structural reorganization.Main Topic:This episode of Oncology Unscripted explores the projected $25 trillion global cost of cancer care, rising cancer incidence, and declining mortality, all set against political and funding uncertainty in frozen Washington, DC.Interview:In this episode of Oncology Unscripted, John Marshall, MD, sits down with Richard Pazdur, MD, former director of the FDA’s Oncology Center of Excellence, for a candid discussion about his transition to and from the FDA, reflecting on what’s been built and what is at risk of being lost. Hosted by Simplecast, an AdsWizz company. See https://pcm.adswizz.comfor information about our collection and use of personal data foradvertising.34 min
About Oncology Unscripted With John Marshall
From the publisher's feed
Oncology Unscripted with John Marshall, MD brings you a unique take on the latest oncology news including business news, gossip, science, and a special in-depth segment relevant to clinical practice.